Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen …
KP Hoeflich, S Herter, J Tien, L Wong, L Berry, J Chan… - Cancer research, 2009 - AACR
Oncogenic activation of the BRAF serine/threonine kinase has been associated with
initiation and maintenance of melanoma tumors. As such, development of pharmacologic …
initiation and maintenance of melanoma tumors. As such, development of pharmacologic …
[PDF][PDF] Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAF V600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase …
KP Hoeflich, S Herter, J Tien, L Wong, L Berry, J Chan… - Cancer Res, 2009 - academia.edu
Oncogenic activation of the BRAF serine/threonine kinase has been associated with
initiation and maintenance of melanoma tumors. As such, development of pharmacologic …
initiation and maintenance of melanoma tumors. As such, development of pharmacologic …
[引用][C] Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase …
KP HOEFLICH, S HERTER, H STERN… - Cancer research …, 2009 - pascal-francis.inist.fr
Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E
Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated …
Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated …
Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status and sustained extracellular signal-regulated kinase/mitogen …
KP Hoeflich, S Herter, J Tien, L Wong, L Berry… - Cancer …, 2009 - europepmc.org
Oncogenic activation of the BRAF serine/threonine kinase has been associated with
initiation and maintenance of melanoma tumors. As such, development of pharmacologic …
initiation and maintenance of melanoma tumors. As such, development of pharmacologic …
Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status and sustained extracellular signal-regulated kinase/mitogen …
KP Hoeflich, S Herter, J Tien, L Wong… - Cancer …, 2009 - pubmed.ncbi.nlm.nih.gov
Oncogenic activation of the BRAF serine/threonine kinase has been associated with
initiation and maintenance of melanoma tumors. As such, development of pharmacologic …
initiation and maintenance of melanoma tumors. As such, development of pharmacologic …
Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen …
KP Hoeflich, S Herter, J Tien, L Wong, L Berry… - Cancer …, 2009 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Oncogenic activation of the BRAF
serine/threonine kinase has been associated with initiation and maintenance of melanoma …
serine/threonine kinase has been associated with initiation and maintenance of melanoma …
[PDF][PDF] Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAF V600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase …
KP Hoeflich, S Herter, J Tien, L Wong, L Berry… - Cancer …, 2009 - pdfs.semanticscholar.org
Oncogenic activation of the BRAF serine/threonine kinase has been associated with
initiation and maintenance of melanoma tumors. As such, development of pharmacologic …
initiation and maintenance of melanoma tumors. As such, development of pharmacologic …
[PDF][PDF] Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAF V600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase …
KP Hoeflich, S Herter, J Tien, L Wong, L Berry, J Chan… - Cancer Res, 2009 - academia.edu
Oncogenic activation of the BRAF serine/threonine kinase has been associated with
initiation and maintenance of melanoma tumors. As such, development of pharmacologic …
initiation and maintenance of melanoma tumors. As such, development of pharmacologic …